Your address will show here +12 34 56 78

Invest in VasoGnosis

This is the only time we opened fundraising to the public, so there is a limited window.

VasoGnosis is NOW LIVE on SeedInvest, an investment platform providing individual and institutional investors access to highly-vetted investment opportunities!

That means you can invest in VasoGnosis during our 45-day fundraising campaign which is now live. This is the only time we opened fundraising to the public, so there is a limited window. During this time, we must hit our fundraising target for it to be considered a successful campaign. If we fall short, the money is returned back in full to the investors.

  • SeedInvest accepted less than 1% of the 40,000+ companies that have applied.
  • There are now over 350,000+ investors on the platform.
  • To date they have raised $185M+ for over 150 startups across all industries and stages.
  • The minimum investment for non-accredited investors is $1,000 USD.
  • The minimum investment for accredited investors is $10,000 USD.

This presentation contains offering materials prepared solely by VasoGnosis Inc. without the assistance of SI Securities, and not subject to FINRA Rule 2210. In addition, this presentation may contain forward-looking statements and information relating to, among other things, the company, its business plan and strategy, and its industry. These statements reflect management’s current views with respect to future events based information currently available and are subject to risks and uncertainties that could cause the company’s actual results to differ materially. Investors are cautioned not to place undue reliance on these forward-looking statements as they contain hypothetical illustrations of mathematical principles, are meant for illustrative purposes, and they do not represent guarantees of future results, levels of activity, performance, or achievements, all of which cannot be made. Moreover, no person nor any other person or entity assumes responsibility for the accuracy and completeness of forward-looking statements, and is under no duty to update any such statements to conform them to actual results.